CD274 and non-small cell lung carcinoma: DLS significantly discriminated between PD-L1 negative and positive patients (all AUC ≥0.8 in three cohorts). DLS combined with clinical characteristics could accurately predict the survival of the NSCLC patients (C-indexes of 0.70-0.87).